InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8100
+0.0075 (0.93%)
At close: Jun 2, 2025, 4:00 PM
0.7808
-0.0292 (-3.60%)
After-hours: Jun 2, 2025, 7:56 PM EDT
InflaRx Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for InflaRx stock ranges from a low of $3.00 to a high of $10. The average analyst price target of $7.75 forecasts a 856.79% increase in the stock price over the next year.
Price Target: $7.75 (+856.79%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for InflaRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 1 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 3 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $6 → $3 | Buy | Maintains | $6 → $3 | +270.37% | May 29, 2025 |
Oppenheimer | Oppenheimer | Buy Initiates $6 | Buy | Initiates | $6 | +640.74% | May 8, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +1,134.57% | Apr 29, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +1,134.57% | Mar 26, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +887.65% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
171.36K
from 165.79K
Increased by 3.36%
Revenue Next Year
343.74K
from 171.36K
Increased by 100.60%
EPS This Year
-0.79
from -0.78
EPS Next Year
-0.73
from -0.79
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 221,550 | 960,750 | 162.1M | ||
Avg | 171,360 | 343,740 | 62.6M | ||
Low | 91,140 | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 33.6% | 460.7% | 47,049.0% | ||
Avg | 3.4% | 100.6% | 18,113.8% | ||
Low | -45.0% | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.72 | -0.47 | 0.23 | ||
Avg | -0.79 | -0.73 | -0.46 | ||
Low | -0.85 | -0.80 | -0.93 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.